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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Pharmacology as a modern science tends to combine many
disciplines both within its theoretical aspects and practical
applications. Indeed, pharmacology, benefits from both stud-
ies and results obtained in other fields such as traditional med-
icine (Ghanemi and Boubertakh, 2015), genetics, physiology
and zoology (Ghanemi, 2015). Pharmacology is even very close
to some specialties such as toxicology (Ghanemi, 2014a,b) and
biology. The current situation strongly links pharmacology
with numerous modern sciences within the context of current
finding and discoveries.
However, herein we would like to put a spotlight on the
importance of ‘‘going back” in the history of biology to ‘‘dig”
and find new elements toward further understanding of princi-
ples and concepts (Hsu, 1962; Alsberg, 1970; Calow, 1983;
Jerison, 2002; Chaitow and Wallden, 2008) that could push
forward the pharmacology. In such a situation, a deep under-
standing of the principles of evolutionary and adaptational
mechanisms would be the starting keys. For instances, explain-
ing the symbiotic mechanisms of organisms could be the
weapon against this organism and describing the development
of organs could lead to a better understanding of the pharma-
cokinetics and the pharmacodynamics. Furthermore, reporting
details about animal’s taxonomy will optimize the species
selection for drug-based assays; and studying the similarities
and the differences between species from an evolutionary view-
point would significantly contribute to the interpretation of
pharmacological tests obtained in different species, allow
acceptable correlations and extrapolation of such results at
divers levels. Moreover, this could improve the development
of animal models of the different diseases such as Alzheimer’s
disease (Ghanemi, 2014c). Importantly, studying the evolution
from a molecular and cellular perspective would enrich the
data we need to develop cellular models of disease or develop
new cell lines used to test drugs (Ghanemi, 2014d). All these
concepts converge toward enlarging the spectrum of the fieldsand disciplines contributing in pharmaceutical development
and further optimize the pharmacological methodologies.
Evolution and biological history are not only for paleontol-
ogists, anthropologists and natural historians; it is also a
necessity for pharmacologists and biologists as well. This
new perspective which requires collaborative efforts could be
the starting point toward further and quicker advances in the
field of drug development and therapies improvement.
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